PROKIDNEY CORP. - 10-Q Filing

ProKidney Corp. reports Q3 2026 financial results including updates on lease liabilities, share-based compensation, and segment operating expenses.

SEC EDGAR ·

Tickers: $PROK

Read the full article at SEC EDGAR

More Regulatory news